The latest health news
The FDA’s approval of the drug Aduhelm as a treatment for Alzheimer’s disease — despite the recommendation of its own advisory committee against approval — came as a surprise to …
Read More
If you think bolstering the pharmaceutical supply chain in the U.S. is a national priority, you could be wrong. Just take a look at the sorry situation in Morgantown, W. …
Read More
Three of the largest pharmaceutical wholesalers and a major drug maker reached a $26 billion deal to settle lawsuits filed by state governments accusing the companies of fomenting the opioid …
Read More
When I learned of the Food and Drug Administration’s approval of aducanumab (Aduhelm) for Alzheimer’s disease, I was struck by the parallels with the agency’s approval of tacrine (Cognex) in …
Read More
On the eve of a widely anticipated trial, Johnson & Johnson (JNJ) has agreed to pay $230 million to the state of New York to settle a lawsuit alleging that …
Read More
Is 23andMe a tech company? Do we really need booster shots of Covid-19 vaccines? And what happens when mRNA goes wrong? We cover all that and more this week on …
Read More
Last week’s controversial decision by the FDA to give aducanumab, Biogen’s Alzheimer’s drug, accelerated approval turned the spotlight on the role of FDA advisory committees. News reports highlighted how the …
Read More
This week’s “First Opinion Podcast” is a special two-part episode focusing on the controversial — some say inflammatory — FDA decision to approve aducanumab, an Alzheimer’s drug developed by Biogen …
Read More
Most visits to the memory center where I care for individuals living with Alzheimer’s disease end in disappointment. “Are there any new treatments, Dr. Karlawish?” patients or family members hopefully …
Read More